Cycloviolacin O14
Need Assistance?
  • US & Canada:
    +
  • UK: +

Cycloviolacin O14

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Cycloviolacin O14 is produced by Viola odorata. It probably participates in a plant defense mechanism. Cycloviolacin O14 has hemolytic activity.

Category
Functional Peptides
Catalog number
BAT-012351
Molecular Formula
C132H197N35O41S6
Molecular Weight
3122.57
IUPAC Name
3-[(1R,4S,7S,13S,16S,22S,25S,28S,31R,34S,37S,43S,46S,49S,52R,55S,58R,64S,70S,73S,76R,79S,85S,88S,91R,94S,97S)-25,46,79-tris(4-aminobutyl)-22-(2-amino-2-oxoethyl)-88-benzyl-13-[(2S)-butan-2-yl]-70-[(1R)-1-hydroxyethyl]-16,49,55,94-tetrakis(hydroxymethyl)-43,73-bis[(4-hydroxyphenyl)methyl]-4,28,85-trimethyl-34-(2-methylpropyl)-2a,3,6,12,15,18,21,24,27,30,33,36,42,45,48,51,54,57,60,63,69,72,75,78,81,84,87,90,93,96,99-hentriacontaoxo-4a,5a,8a,9a,12a,13a-hexathia-1a,2,5,11,14,17,20,23,26,29,32,35,41,44,47,50,53,56,59,62,68,71,74,77,80,83,86,89,92,95,98-hentriacontazaheptacyclo[56.44.4.431,76.452,91.07,11.037,41.064,68]tetradecahectan-97-yl]propanoic acid
Sequence
GSIPACGESCFKGKCYTPGCSCSKYPLCAKN
InChI
InChI=1S/C132H197N35O41S6/c1-9-66(4)104-131(207)167-45-21-28-96(167)128(204)143-69(7)108(184)158-89-59-209-210-60-90-123(199)156-88(58-171)120(196)162-94-64-214-213-63-93(161-119(195)87(57-170)155-114(190)79(38-39-103(180)181)145-100(177)52-139-110(89)186)125(201)150-81(47-71-22-11-10-12-23-71)115(191)141-67(5)106(182)137-51-99(176)144-76(24-13-16-40-133)111(187)159-92(124(200)151-82(48-72-30-34-74(173)35-31-72)117(193)164-105(70(8)172)132(208)166-44-19-27-95(166)127(203)140-54-102(179)147-90)62-212-211-61-91(122(198)142-68(6)107(183)148-77(25-14-17-41-134)112(188)152-83(50-98(136)175)109(185)138-53-101(178)146-85(55-168)121(197)163-104)160-116(192)80(46-65(2)3)153-129(205)97-29-20-43-165(97)130(206)84(49-73-32-36-75(174)37-33-73)154-113(189)78(26-15-18-42-135)149-118(194)86(56-169)157-126(94)202/h10-12,22-23,30-37,65-70,76-97,104-105,168-174H,9,13-21,24-29,38-64,133-135H2,1-8H3,(H2,136,175)(H,137,182)(H,138,185)(H,139,186)(H,140,203)(H,141,191)(H,142,198)(H,143,204)(H,144,176)(H,145,177)(H,146,178)(H,147,179)(H,148,183)(H,149,194)(H,150,201)(H,151,200)(H,152,188)(H,153,205)(H,154,189)(H,155,190)(H,156,199)(H,157,202)(H,158,184)(H,159,187)(H,160,192)(H,161,195)(H,162,196)(H,163,197)(H,164,193)(H,180,181)/t66-,67-,68-,69-,70+,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,104-,105-/m0/s1
InChI Key
BIAIZYAAHSRWFZ-UBDVFVGDSA-N
Canonical SMILES
CCC(C)C1C(=O)N2CCCC2C(=O)NC(C(=O)NC3CSSCC4C(=O)NC(C(=O)NC5CSSCC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N1)CO)CC(=O)N)CCCCN)C)NC(=O)C(NC(=O)C6CCCN6C(=O)C(NC(=O)C(NC(=O)C(NC5=O)CO)CCCCN)CC7=CC=C(C=C7)O)CC(C)C)C(=O)NC(C(=O)NC(C(=O)N8CCCC8C(=O)NCC(=O)N4)C(C)O)CC9=CC=C(C=C9)O)CCCCN)C)CC1=CC=CC=C1)NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCC(=O)O)CO)CO)C
1. The anthelmintic activity of the cyclotides: natural variants with enhanced activity
Michelle L Colgrave, Andrew C Kotze, David C Ireland, Conan K Wang, David J Craik Chembiochem. 2008 Aug 11;9(12):1939-45. doi: 10.1002/cbic.200800174.
The cyclotides are a family of backbone-cyclised cystine-knot-containing peptides from plants that possess anthelmintic activity against Haemonchus contortus and Trichostrongylus colubriformis, two important gastrointestinal nematode parasites of sheep. In the current study, we investigated the in vitro effects of newly discovered natural cyclotides on the viability of larval and adult life stages of these pests. The natural variants cycloviolacin O2, cycloviolacin O3, cycloviolacin O8, cycloviolacin O13, cycloviolacin O14, cycloviolacin O15, and cycloviolacin O16 extracted from Viola odorata showed up to 18-fold greater potency than the prototypic cyclotide kalata B1 in nematode larval development assays. Cycloviolacin O2 and cycloviolacin O14 were significantly more potent than kalata B1 in adult H. contortus motility assays. The lysine and glutamic acid residues of cycloviolacin O2, the most potent anthelmintic cyclotide, were chemically modified to investigate the role of these charged residues in modulating the biological activity. The single glutamic acid residue, which is conserved across all known cyclotides, was shown to be essential for activity, with a sixfold decrease in potency of cycloviolacin O2 following methylation. The three lysine residues present in cycloviolacin O2 were acetylated to effectively mask the positive charge, resulting in a 18-fold decrease in anthelmintic activity. The relative anthelmintic activities of the natural variants assayed against nematode larvae correlated with the number of charged residues present in their sequence.
2. Cyclotides as natural anti-HIV agents
David C Ireland, Conan K L Wang, Jennifer A Wilson, Kirk R Gustafson, David J Craik Biopolymers. 2008;90(1):51-60. doi: 10.1002/bip.20886.
Cyclotides are disulfide rich macrocyclic plant peptides that are defined by their unique topology in which a head-to-tail cyclized backbone is knotted by the interlocking arrangement of three disulfide bonds. This cyclic cystine knot motif gives the cyclotides exceptional resistance to thermal, chemical, or enzymatic degradation. Over 100 cyclotides have been reported and display a variety of biological activities, including a cytoprotective effect against HIV infected cells. It has been hypothesized that cyclotides from one subfamily, the Möbius subfamily, may be more appropriate than bracelet cyclotides as drug candidates given their lower toxicity to uninfected cells. Here, we report the anti-HIV and cytotoxic effects of three cyclotides, including two from the Möbius subfamily. We show that Möbius cyclotides have comparable inhibitory activity against HIV infection to bracelet cyclotides and that they are generally less cytotoxic to the target cells. To explore the structure activity relationships (SARs) of the 29 cyclotides tested so far for anti-HIV activity, we modeled the structures of the 21 cyclotides whose structures have not been previously solved. We show that within cyclotide subfamilies there is a correlation between hydrophobicity of certain loop regions and HIV inhibition. We also show that charged residues in these loops impact on the activity of the cyclotides, presumably by modulating membrane binding. In addition to providing new SAR data, this report is a mini-review that collates all cyclotide anti-HIV information reported so far and provides a resource for future studies on the therapeutic potential of cyclotides as natural anti-HIV agents.
3. Anthelmintic activity of cyclotides: In vitro studies with canine and human hookworms
Michelle L Colgrave, Andrew C Kotze, Steven Kopp, James S McCarthy, Glen T Coleman, David J Craik Acta Trop. 2009 Feb;109(2):163-6. doi: 10.1016/j.actatropica.2008.11.003. Epub 2008 Nov 18.
Hookworm infection is a leading cause of maternal and child morbidity in countries of the tropics and subtropics, as well as being an important parasite in companion-animal medicine. The cyclotides are a novel family of cyclic cystine knot containing peptides from plants that have been shown to possess anthelmintic activity against Haemonchus contortus and Trichostrongylus colubriformis, two important gastrointestinal nematodes of sheep. In the current study we demonstrated the in vitro effects of three representative cyclotides, kalata B1, kalata B6 and cycloviolacin O14, on the viability of larval and adult life stages of the dog hookworm Ancylostoma caninum, and larvae of the human hookworm Necator americanus. The cyclotides showed significant anthelmintic activity towards both hookworm species. The different cyclotides showed similar patterns of relative activity as that seen previously with the livestock nematode species. This study demonstrates that cyclotides have promising activity in vitro against important parasites of companion animals and humans.
Online Inquiry
Verification code
Inquiry Basket